1.Abbott Laboratories
ABT (NYSE)
Abbott Laboratories stands out as a U.S. healthcare company known for its reliable dividend growth and diverse portfolio spanning diagnostics, devices, and nutrition. Despite a challenging year with a -14.19% return, it offers an attractive dividend yield of 2.78%, appealing to income-focused investors. Analysts remain optimistic, maintaining a median 12-month price target of $121, with recommendations from firms like TD Cowen and Citigroup reflecting a Buy rating, highlighting its strong market position.
Pros:
- Consistent dividend growth
- Broad exposure across healthcare sectors
Cons:
- Negative returns in recent years
- Market competition in healthcare
2.The Coca-Cola Company
KO (NYSE)
The stock boasts a solid dividend yield of 2.33% and impressive returns of 29.70% over the past year and 60.41% over the past five years, indicating strong performance. Analysts are optimistic, with a median 12-month price target of $95.00, reflecting potential upside, while ratings from firms like Argus Research and Barclays suggest a buy or overweight position. Investors may find this combination of yield and growth appealing as part of their portfolio strategy.
Pros:
- Strong 1-year and 5-year returns
- Consistent dividend payments
Cons:
- Dependence on beverage market trends
- Potential for market saturation
3.ProShares S&P 500 Dividend Aristocrats ETF
NOBL (BATS)
The ProShares S&P 500 Dividend Aristocrats ETF is an attractive option for investors seeking exposure to dividend-growth stocks from financially healthy companies. With a dividend yield of 2.10%, it offers reliable income while delivering a solid one-year return of 10.81% and a remarkable five-year return of 23.94%. This ETF tracks the S&P 500 Dividend Aristocrats index, providing a diversified basket of dividend growers that can enhance your investment strategy.
Pros:
- Diversified investment in dividend growers
- Strong historical performance
Cons:
- Market risk exposure
- Dependence on index performance
4.Johnson & Johnson
JNJ (NYSE)
Johnson & Johnson stands out as a U.S. healthcare blue chip, recognized for its strong cash flow and a remarkable history of dividend growth, making it an attractive option for income-focused investors. With a 1.93% dividend yield and impressive 1-year and 5-year returns of 51.12% and 54.49% respectively, the company's financial health is evident. Analysts maintain a positive outlook, with a median 12-month price target of $282.00, reflecting strong confidence in its market performance.
Pros:
- Strong dividend growth history
- Resilient cash flow
Cons:
- Exposure to regulatory risks
- Market competition in healthcare
5.The Procter & Gamble Company
PG (NYSE)
With a dividend yield of 2.91%, this investment offers steady income potential, although it has faced challenges, reflected in a 1-year return of -8.77% and a modest 5-year return of only 0.62%. Analysts maintain a median 12-month price target of $162, with a range between $142 and $172, suggesting some upside potential; however, recent downgrades from Argus Research and HSBC indicate cautious sentiment. Overall, the mixed analyst ratings—B+ with a split between 'Hold' and 'Buy'—signal a need for careful consideration before investing.
Pros:
- Stable dividend payments
- Strong market presence
Cons:
- Negative 1-year return
- Market volatility risk
Did you know?
Dividend Aristocrats are S&P 500 companies that have raised dividends for at least 25 consecutive years. This list focuses on that quality bar: compare current yield, sector mix, and valuation versus the broader market.
Final Words
As you consider your investment options this September, keep in mind the potential of dividend aristocrats like Procter & Gamble. Take time to compare your choices and conduct thorough research to ensure your portfolio aligns with your financial goals.
Frequently Asked Questions
The current dividend yield of Procter & Gamble is approximately 2.91%. This yield reflects the annual dividends paid relative to the company's share price.
The next dividend payment for Procter & Gamble is $1.0885, which is scheduled for distribution quarterly. The previous dividend date was on August 17, 2026.
Over the past year, Procter & Gamble has reported a return of -8.77%. This reflects the company's stock performance and market conditions affecting its value.
Investing in dividend aristocrats carries risks such as market volatility, economic downturns, and changes in consumer preferences. While these companies often have a reliable track record of dividend payments, external factors can impact their performance.
Procter & Gamble is a strong contender among dividend aristocrats, known for its stability and consistent dividend payments. When comparing it to others, consider factors like market cap, sector performance, and historical returns to assess its relative strength.
Procter & Gamble has a market capitalization of approximately $340.40 billion. This figure reflects the total market value of the company's outstanding shares.
